Pharmaceuticals

FDA approves Galderma’s Nemrubio for adults with prurigo nodularis

bexib
By bexib 0 Min Read

Nemluvio’s approval was based on positive results from the Phase 3 OLYMIA trial, which showed significant reduction in itch.

You Might Also Like

FDA Grants Accelerated Approval to Bristol-Myers Squibb’s Crazaty for Previously Treated, Locally Advanced or Metastatic Colorectal Cancer

BMS’ long-time leukemia blockbuster faces first generic challenge

New study reveals how brain cell communication is linked to Alzheimer’s disease

Non-compete clauses and the nursing shortage: Q&A with Matt Hollingsworth

Pharma Pulse 8/16/24: DCTS: Bankruptcy or Breakthrough? U.S. Drug Pricing Initiative Saves Over $7.5 Billion

Share This Article
Previous Article Secondary consideration of unintended consequences
Next Article Explore Today’s Hot Stock Market – Investorempires.com
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay Connected

Latest News

Revolut launches robo-advisor in Singapore
Fintech
This hurricane season, do your customers know the difference between homeowners insurance and flood insurance?
Insurance
Crypto.com launches US institutional exchange
Fintech
Trafalgar St James unveils Rockwell Bistro & Wine Bar; first phase of hotel’s £6m refurbishment
Hospitality & Tourism